摘要 |
Disclosed is a compound of formula I e.g. (N-(2-cyclohexyl-5,6-dimethylpyrimiidin-4-yl)-5-fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine or a pharmaceutically acceptable salt thereof, wherein Ht, ring D, Z1, RX, RY is defined in the specification for treating or lessening the severity of a disease or condition selected from diabetes, osteoporosis, Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS-associated dementia, bipolar disorder, amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), multiple sclerosis (MS), schizophrenia, leukocytopenia, stroke, and rheumatoid arthritis. |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED |
发明人 |
JIMENEZ, JUAN-MIGUEL;MILLER, ANDREW;GREEN, JEREMY;GAO, HUAI;HENKEL, GREGORY;LIU, MICHAEL;NEUBERGER, TIMOTHY |